University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Robert Kerlan, M.D.

Chief of interventional radiology

Dr. Robert K. Kerlan is chief of Interventional Radiology at UCSF Medical Center. He is particularly interested in the management of liver disease, including biliary disease, portal hypertension and hepatic malignancy. In his research, he is working to devleop new procedures to diagnose and treat patients with problems related to living donor organ transplants.

Kerlan earned a medical degree at the University of Southern California in Los Angeles. He completed a radiology residency at UCSF and served as chief radiology resident. He is a member of several professional organizations, including his election as a fellow of the Society of Cardiovascular and Interventional Radiology. He is a professor of clinical radiology at UCSF.

Clinics

Comprehensive Fibroid Center
2356 Sutter St., Sixth Floor
San Francisco, CA 94143-1648
Phone: (415) 885-7788
Fax: (415) 353-9550

Hours: Monday to Friday
8 a.m. – 5 p.m.

Interventional Radiology
505 Parnassus Ave., Room M-361
San Francisco, CA 94143
Phone: (415) 353-1300
Appointments: (415) 353-2573
Billing: 415) 514-8888
Fax: (415) 353-8570

Hours: Monday to Friday
8:30 a.m. – 5 p.m.

Liver Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 353-1888
Fax: (415) 353-8917

Hours: Pre-Liver Transplant Clinic Monday, Tuesday 7 a.m. – 12 p.m.
Hours: Post-Liver Transplant Clinic Tuesday 8 a.m. – 12 p.m.

Radiology at Divisadero St.
1600 Divisadero St., Room A-142 and A-219
San Francisco, CA 94115
Scheduling: (415) 353-2573
CT, MRI and Bone Densitometry: (415) 885-7282
X-Ray and Nuclear Medicine:
(415) 885-3822
Interventional Radiology:
(415) 885-3578
Fax: (415) 353-7140

Hours: Monday to Friday,
8 a.m. – 5 p.m.

Radiology at the Ambulatory Care Center
400 Parnassus Ave.
San Francisco, CA 94143
Scheduling: (415) 353-2666
Phone (Interventional Radiology): (415) 353-1300
Fax: (415) 353-7140

Hours: Monday to Friday
7:30 a.m. – 5:30 p.m.

Conditions & Treatments

More about Robert Kerlan

Education

University of Southern California School of Medicine 1977

Residencies

UCSF Medical Center, Diagnostic Radiology 1981

Selected Research and Publications

  1. Kohi MP, Naeger DM, Lorenson MJ, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. Hook, line, and sinker: hook wire localization of a retained suture needle in the perineum. J Vasc Interv Radiol. 2014 Sep; 25(9):1479-80.
  2. Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP. (90)Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. J Gastrointest Cancer. 2014 Jun; 45(2):168-80.
  3. Price AJ, Fidelman N, Wilson MW, Kerlan RK. Percutaneous interventions in failing "necklace" hemodialysis grafts: long-term outcomes. J Vasc Interv Radiol. 2014 Feb; 25(2):199-205.
  4. Kuo YC, Kohi MP, Naeger DM, Tong RT, Kolli KP, Taylor AG, Laberge JM, Kerlan RK, Fidelman N. Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 2013 Oct; 36(5):1336-43.
  5. Veal DR, Lee AY, Kerlan RK, Gordon RL, Fidelman N. Outcomes of metallic biliary stent insertion in patients with malignant bilobar obstruction. J Vasc Interv Radiol. 2013 Jul; 24(7):1003-10.
  6. Kohi MP, Fidelman N, Kerlan RK. Reply to ?Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?? J Vasc Interv Radiol. 2013 Jul; 24(7):1076.
  7. Olorunsola OG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK. Failure of filter reexpansion during unsuccessful retrieval of Option inferior vena cava filter. J Vasc Interv Radiol. 2013 Jul; 24(7):1065-7.
  8. Johnson DT, Durack JC, Fidelman N, Kerlan RK, LaBerge JM. Distribution of reported StarClose SE vascular closure device complications in the manufacturer and user facility device experience database. J Vasc Interv Radiol. 2013 Jul; 24(7):1051-6.
  9. Tong RT, Kohi M, Fidelman N, Kuo YC, Foster R, Peled A, Kolli KP, Taylor AG, LaBerge JM, Kerlan RK. Clinical outcomes of percutaneous drainage of breast fluid collections after mastectomy with expander-based breast reconstruction. J Vasc Interv Radiol. 2013 Sep; 24(9):1369-74.
  10. Marshall D, Laberge JM, Firetag B, Miller T, Kerlan RK. The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice. J Vasc Interv Radiol. 2013 Aug; 24(8):1094-103.
  11. Durack JC, Wang JH, Sebro R, Zhang KK, Hoch S, Kerlan RK. Prospective evaluation of absorbable gastropexy anchor indwelling time in 33 patients. J Vasc Interv Radiol. 2013 Sep; 24(9):1377-80.
  12. Kohi MP, Naeger DM, Kukreja J, Fidelman N, Laberge JM, Gordon RL, Kerlan RK. Preoperative CT-Guided percutaneous wire localization of ground glass pulmonary nodules with a modified Kopans wire. J Thorac Dis. 2013 Apr; 5(2):E31-4.
  13. Burke C, Taylor AG, Ring EJ, Kerlan RK. Creation of a percutaneous mesocaval shunt to control variceal bleeding in a child. Pediatr Radiol. 2013 Sep; 43(9):1218-20.
  14. Olorunsola OG, Kohi MP, Fidelman N, Westphalen AC, Kolli PK, Taylor AG, Gordon RL, LaBerge JM, Kerlan RK. Caval penetration by retrievable inferior vena cava filters: a retrospective comparison of Option and G√ľnther Tulip filters. J Vasc Interv Radiol. 2013 Apr; 24(4):566-71.
  15. Garwood ER, Fidelman N, Hoch SE, Kerlan RK, Yao FY. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl. 2013 Feb; 19(2):164-73.
  16. Arrayeh E, Fidelman N, Gordon RL, LaBerge JM, Kerlan RK, Klimov A, Bloom AI. Transcatheter arterial embolization for upper gastrointestinal nonvariceal hemorrhage: is empiric embolization warranted? Cardiovasc Intervent Radiol. 2012 Dec; 35(6):1346-54.
  17. Kohi MP, Fidelman N, Naeger DM, LaBerge JM, Gordon RL, Kerlan RK. Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol. 2013 Jan; 24(1):68-73.
  18. Lee AY, Gregorius J, Kerlan RK, Gordon RL, Fidelman N. Percutaneous transhepatic balloon dilation of biliary-enteric anastomotic strictures after surgical repair of iatrogenic bile duct injuries. PLoS One. 2012; 7(10):e46478.
  19. Fidelman N, Kwan SW, LaBerge JM, Gordon RL, Ring EJ, Kerlan RK. The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol. 2012 Oct; 199(4):746-55.
  20. Durack JC, Hope TA, Seo Y, Saeed M, He J, Wilson MW, Kerlan RK, Ring EJ. Intravenous vasopressin for the prevention of nontarget gastrointestinal embolization during liver-directed cancer treatment: experimental study in a porcine model. J Vasc Interv Radiol. 2012 Nov; 23(11):1505-12.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.